share_log

UPDATE 1-Trade commission finds Chinese mattress imports hurt U.S. industry

UPDATE 1-Trade commission finds Chinese mattress imports hurt U.S. industry

更新1-貿易委員會發現中國牀墊進口損害了美國產業
路透社 ·  2019/11/20 03:53

(Adds background)
   WASHINGTON, Nov 19 (Reuters) - The U.S. International Trade Commission on Tuesday concluded that U.S. industry is materially injured by Chinese-made mattresses that are sold at less than fair value, paving the way for the U.S. Commerce Department to impose anti-dumping duties.
   The commission said in a statement it made a negative finding regarding critical circumstances regarding the mattress imports, which meant that such imports would not be subject to retroactive anti-dumping duties.
   It said a full report would be published by Dec. 30.
   The Commerce Department in May said it had determined that Chinese-made mattresses were being dumped in the U.S. market at less than fair value, and that it would impose preliminary anti-dumping duties, ranging from 57% up to 1,731%.
   Major U.S. mattress firms had petitioned for relief, including Serta Simmons Bedding LLC, Leggett & Platt Inc  and Tempur Sealy International Inc .
   In 2017, the United States imported $436.5 million in Chinese-made mattresses, the Commerce Department said. The duties cover adult mattresses ranging from twin to California king size and crib or youth mattresses.

(Reporting by Andrea Shalal; Editing by Lisa Shumaker and Nick
Zieminski)
((andrea.shalal@tr.com; +1 202-815-7432;)

(增加背景)路透華盛頓11月19日電-美國國際貿易委員會(U.S.International Trade Commission)週二得出結論,中國製造的牀墊以低於公允價值的價格出售,對美國工業造成了實質性損害,為美國商務部徵收反傾銷税鋪平了道路。歐盟委員會在一份聲明中表示,它對牀墊進口的關鍵情況做出了負面調查,這意味着此類進口將不會受到追溯性反傾銷税的影響。該公司表示,完整的報告將在12月30日之前發佈。美國商務部5月份表示,已確定中國製造的牀墊在美國市場以低於公允價值的價格傾銷,並將徵收初步反傾銷税,税率從57%到1731%不等。美國主要的牀墊公司已經請願要求救濟,包括Serta Simmons Bedding LLC,Leggett&Platt Inc和Tempur Sealy International Inc.。商務部表示,2017年,美國進口了價值4.365億美元的中國製造牀墊。這些關税涵蓋成人牀墊,從雙人牀墊到加州特大牀墊,以及嬰兒牀或青少年牀墊。(Andrea Shalal報道;Lisa Shumaker和Nick編輯齊明斯基)(andrea.shalal@tr.com;+1 202-815-7432;)

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論